Literature DB >> 16872025

Popliteal-to-distal artery bypass for diabetic limb salvage.

A E Brannigan1, K Ahmad, M Tubassum, M Clarke Moloney, P A Grace, P E Burke.   

Abstract

BACKGROUND: Poor long-term survival and significant co-morbidity among diabetic patients with limb ischaemia makes the shortest, simplest revascularisation procedure desirable. AIM: Evaluate limb salvage, primary graft patency and peri-operative morbidity rates in diabetic patients undergoing popliteal-to-distal artery bypass for limb salvage.
METHODS: Patients undergoing popliteal-to-distal artery bypass for critical limb ischaemia over a seven-year period were retrospectively identified. Patients operative and follow-up data were entered into a database and limb salvage and patient survival determined using Kaplan Meier survival analysis.
RESULTS: During the study period 21 popliteal-to-distal artery bypasses were performed on 19 diabetic patients. Mortality rate after one year was 11%. Primary graft patency rates among surviving patients was 81%, 67% and 48% at 1, 2 and 6 years respectively. Amputation was required in three patients.
CONCLUSION: Popliteal-to-distal artery bypass produces favourable results in high-risk diabetic patients with critical limb ischaemia.

Entities:  

Mesh:

Year:  2006        PMID: 16872025     DOI: 10.1007/bf03167945

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  13 in total

1.  A twelve-year experience with the popliteal-to-distal artery bypass: the significance and management of proximal disease.

Authors:  K R Wengerter; P M Yang; F J Veith; S K Gupta; T F Panetta
Journal:  J Vasc Surg       Date:  1992-01       Impact factor: 4.268

2.  Infrainguinal reconstructions: influence of surgical experience on outcome.

Authors:  M Luther; M Lepäntalo
Journal:  Cardiovasc Surg       Date:  1998-08

3.  Long-term results of infragenicular bypasses with autogenous vein originating from the distal superficial femoral and popliteal arteries.

Authors:  M S Rosenbloom; J J Walsh; J J Schuler; J P Meyer; T H Schwarcz; J Eldrup-Jorgensen; J R Durham; D P Flanigan
Journal:  J Vasc Surg       Date:  1988-05       Impact factor: 4.268

Review 4.  Basic data related to the natural history of intermittent claudication.

Authors:  M D McDaniel; J L Cronenwett
Journal:  Ann Vasc Surg       Date:  1989-07       Impact factor: 1.466

5.  Distal tibial arterial bypass. Analysis of 91 cases.

Authors:  G P Noon; E B Diethrich; W P Richardson; M E DeBakey
Journal:  Arch Surg       Date:  1969-12

6.  Early experience with popliteal to infrapopliteal bypass for limb salvage.

Authors:  J J Schuler; D P Flanigan; L R Williams; T J Ryan; J J Castronuovo
Journal:  Arch Surg       Date:  1983-04

7.  Superficial femoral and popliteal arteries as inflow sites for distal bypasses.

Authors:  F J Veith; S K Gupta; R H Samson; S W Flores; G Janko; L A Scher
Journal:  Surgery       Date:  1981-12       Impact factor: 3.982

8.  Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene.

Authors:  P A Schneider; M T Caps; D Y Ogawa; E S Hayman
Journal:  J Vasc Surg       Date:  2001-05       Impact factor: 4.268

9.  Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus.

Authors:  F B Pomposelli; E J Marcaccio; G W Gibbons; D R Campbell; D V Freeman; A M Burgess; A Miller; F W LoGerfo
Journal:  J Vasc Surg       Date:  1995-03       Impact factor: 4.268

10.  Effect of inflow and outflow sites on the results of tibioperoneal vein grafts.

Authors:  A N Sidawy; J O Menzoian; N L Cantelmo; F W LoGerfo
Journal:  Am J Surg       Date:  1986-08       Impact factor: 2.565

View more
  1 in total

1.  Popliteo-pedal bypass surgery for critical limb ischemia.

Authors:  D W Good; Hasan Al Chalabi; H Al Chalabi; F Hameed; B Egan; S Tierney; T M Feeley
Journal:  Ir J Med Sci       Date:  2011-07-29       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.